title: The role of antinuclear autoantibodies in patients with psoriasis treated with anti-tumor necrosis factor-alpha agents: a retrospective long-term study.
authors.forename: Rosita
authors.initials: R
authors.lastname: Saraceno
authors.forename: Francesca
authors.initials: F
authors.lastname: Specchio
authors.forename: Tiago
authors.initials: T
authors.lastname: Torres
authors.forename: Steven Paul
authors.initials: SP
authors.lastname: Nisticò
authors.forename: Stefano
authors.initials: S
authors.lastname: Rizza
authors.forename: Sergio
authors.initials: S
authors.lastname: Chimenti
mesh_terms: D000328:Adult; D000368:Aged; D000974:Antibodies, Antinuclear / Q000187:drug effects / Q000276:immunology*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D015331:Cohort Studies; D016001:Confidence Intervals; D004334:Drug Administration Schedule; D004351:Drug Resistance / Q000276:immunology; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D000069285:Infliximab; D016015:Logistic Models; D008134:Long-Term Care; D008297:Male; D008875:Middle Aged; D016017:Odds Ratio; D011565:Psoriasis / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology*; D012189:Retrospective Studies; D018570:Risk Assessment; D013997:Time Factors; D017211:Treatment Failure
chemical_list: D000974:Antibodies, Antinuclear; D000911:Antibodies, Monoclonal; D000069285:Infliximab